Please wait while we open this resource.
K
Clinical reviews
LARYNGEAL COMPLICATIONS AFTER TRACHEAL INTUBATION AND TRACHEOSTOMY
Manchester Academic Critical Care, Wythenshawe Hospital, Manchester, UK
PDF20218 pages471 KB
The document provides a comprehensive review of laryngeal complications that can arise after tracheal intubation and tracheostomy. It highlights the significant consequences these complications can have on patients recovering from critical illness, including psychological impacts and the importance of early intervention. The article also outlines various management strategies that involve collaboration with speech and language therapists to promote recovery and vocalization.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
LEFT VENTRICULAR-ARTERIAL COUPLING IN SEPTIC SHOCK: A PHYSIOLOGICAL REVIEW
Same clinical topic · Critical Care
CENTRAL VENOUS PRESSURE REVISITED: PHYSIOLOGY, PITFALLS, MISCONCEPTIONS, AND MODERN CLINICAL INTERPRETATION IN CRITICAL CARE
Same clinical topic · Critical Care
HOW I PERSONALIZE FLUID THERAPY IN SEPTIC SHOCK?
Same clinical topic · Critical Care
PRINCIPLES OF FLUID MANAGEMENT
Same clinical topic · Critical Care
ANEMIA OF CRITICAL ILLNESS: A CONCISE DEFINITIVE REVIEW IN CRITICAL CARE
Same clinical topic · Critical Care
NON-INTERVENTIONAL FOLLOW-UP VERSUS FLUID BOLUS IN RESPONSE TO OLIGURIA IN HEMODYNAMICALLY STABLE CRITICALLY ILL PATIENTS: A RANDOMIZED CONTROLLED PILOT TRIAL
Same clinical topic · Critical Care
LONG-TERM EFFECTS OF RESTRICTION OF INTRAVENOUS FLUID IN ADULT ICU PATIENTS WITH SEPTIC SHOCK
Same clinical topic · Critical Care
ASSOCIATION BETWEEN COMBINATION ANTIBIOTIC THERAPY AS OPPOSED TO MONOTHERAPY AND OUTCOMES OF ICU PATIENTS WITH PSEUDOMONAS AERUGINOSA VENTILATOR-ASSOCIATED PNEUMONIA: AN ANCILLARY STUDY OF THE IDIAPASON TRIAL
Same clinical topic · Critical Care
INTERFERON GAMMA - 1B FOR THE PREVENTION OF HOSPITAL - ACQUIRED PNEUMONIA IN CRITICALLY ILL PATIENTS: A PHASE 2, PLACEBO - CONTROLLED RANDOMIZED CLINICAL TRIAL
Same clinical topic · Critical Care